Purpose: The comprehensive behavioral intervention for tics (CBIT) is the first-line psychotherapeutic treatment for individuals with tic disorders. However, most patients with tic disorders do not have access to CBIT due to different factors including lack of trained therapists, treatment cost, and travel distance. Such barriers are more prominent in non-English speaking countries. Therefore, the current study assessed the preliminary efficacy, feasibility, and acceptability of remotely administered group CBIT (RG-CBIT) in Japan. Methods: This was an open-case series that adopted the AB design. Three Japanese children aged between 6 and 13 years who were diagnosed with TS were recruited. RG-CBIT was developed based on the published CBIT manual. Videoconference application, slide presentation software, and cloud learning platform were used as appropriate. Results: The Yale Global Tic Severity Scale scores of all participants decreased from baseline to post-treatment. That is, the score reduced by an average of 7.0. Regarding feasibility and acceptability, the attendance rate of participants was 100%, and the process measurement items had favorable scores. Conclusions: RG-CBIT had satisfactory efficacy, feasibility, and acceptability. Hence, it could mitigate the barriers for treatment access.
Purpose: The comprehensive behavioral intervention for tics (CBIT) is the first-line psychotherapeutic treatment for individuals with tic disorders. However, most patients with tic disorders do not have access to CBIT due to different factors including lack of trained therapists, treatment cost, and travel distance. Such barriers are more prominent in non-English speaking countries. Therefore, the current study assessed the preliminary efficacy, feasibility, and acceptability of remotely administered group CBIT (RG-CBIT) in Japan. Methods: This was an open-case series that adopted the AB design. Three Japanese children aged between 6 and 13 years who were diagnosed with TS were recruited. RG-CBIT was developed based on the published CBIT manual. Videoconference application, slide presentation software, and cloud learning platform were used as appropriate. Results: The Yale Global Tic Severity Scale scores of all participants decreased from baseline to post-treatment. That is, the score reduced by an average of 7.0. Regarding feasibility and acceptability, the attendance rate of participants was 100%, and the process measurement items had favorable scores. Conclusions: RG-CBIT had satisfactory efficacy, feasibility, and acceptability. Hence, it could mitigate the barriers for treatment access.
Tics are sudden, repetitive, non-rhythmic movements (i.e., motor tics) or vocalizations (i.e., vocal tics). Tic disorder is one of the neurodevelopmental disorders characterized by motor and/or vocal tics that begin in childhood. Tics may persist, and the type of tics can change over time. Symptom severity commonly peaks at the early years of teenage life (1). Chronic tic disorder (CTD) is characterized by tics lasting more than 1 year, and tics may be either motor or vocal, but not both. Tourette’s disorder (TD), also known as Tourette syndrome (TS), is characterized by the presence of one or more chronic multiple motor and vocal tics (2). In a previous meta-analysis, the prevalence of TS was 0.77%, and TS is more common in boys (3).In most cases, tic disorders are mild to moderate, and they do not always require treatment. However, if tics are severe or children experience several psychosocial problems, such as deteriorating relationships with family and friends and interference with school and extracurricular activities, then treatment is required (4). The comprehensive behavioral intervention for tics (CBIT) is the first-line treatment for individuals with tic disorders (5). Woods and colleagues developed CBIT (6), which includes the core therapeutic components of psychoeducation, functional assessments and interventions (FAI), habit reversal training (HRT), and relaxation training (Figure 1). CBIT was designed to include eight sessions weekly for 10 weeks, followed by periodic booster session(s) to maintain treatment gains and to learn how to deal with tics that may emerge in the future. The first two sessions last 90 min (combined 180 min), during which patients and their parents receive psychoeducation about tics and learn the basics of the functional assessments/interventions and HRT procedures. The remaining sessions last 60 min and focus on administering core therapeutic components to additional tics and teaching patients and their parents regarding relaxation skills. CBIT was initially tested among children aged 9 years and older. However, a recent study showed that CBIT is effective in young children aged between 5 and 8 years, incorporating enjoyable and ingenious elements of the game called “the opposite game” (7). In this study, the authors highlighted that involving parents in behavioral interventions for young children improves the acceptability, efficacy, and durability.
FIGURE 1
Difference between RG-CBIT and standard CBIT. FAI, functional assessments and interventions; HRT, habit reversal training; RG-CBIT, remotely administered group comprehensive behavioral intervention for tics; CBIT, comprehensive behavioral intervention for tics. The upper part (A) is a schematic diagram of the standard CBIT, and the lower part (B) is a schematic diagram of RG-CBIT. The dark gray cells indicate core therapeutic components. There were three primary differences between RG-CBIT and the standard CBIT (underline and bold text). First, the duration of all sessions were changed to 60 min. Second, the learning relaxation components were moved to the first session. Third, the core therapeutic components were trained in the first four sessions (combined 240 min) rather than the first two sessions (combined 180 min).
Difference between RG-CBIT and standard CBIT. FAI, functional assessments and interventions; HRT, habit reversal training; RG-CBIT, remotely administered group comprehensive behavioral intervention for tics; CBIT, comprehensive behavioral intervention for tics. The upper part (A) is a schematic diagram of the standard CBIT, and the lower part (B) is a schematic diagram of RG-CBIT. The dark gray cells indicate core therapeutic components. There were three primary differences between RG-CBIT and the standard CBIT (underline and bold text). First, the duration of all sessions were changed to 60 min. Second, the learning relaxation components were moved to the first session. Third, the core therapeutic components were trained in the first four sessions (combined 240 min) rather than the first two sessions (combined 180 min).A controlled clinical study has shown that CBIT, similar to pharmacologic treatment, can improve tics in children and adults without causing significant side effects (8–10). Although CBIT is effective, several children with CTD and TS cannot access CBIT because of several factors including lack of trained therapists, treatment cost, travel distance, and time commitment (11–13). CBIT is not widely available particularly in non-English speaking countries (14). To address these barriers and to promote CBIT dissemination, controlled trials of remote administration, such as telehealth and internet-delivered psychotherapy, have been carried out recently. Himle et al. conducted a small randomized controlled trial (RCT) comparing CBIT delivered using the videoconference system and traditional face-to-face CBIT (15). Results showed that both formats were equally beneficial to children with tic disorders. In addition to CBIT, a large long-term follow-up study of ERP is underway in the United Kingdom. Remote Administration is an emerging and significant topic in behavioral therapy (16).Group CBIT is another method that can increase treatment accessibility. Zimmerman-Brenner et al. conducted an RCT of group CBIT and group educational intervention. Results showed that group CBIT significantly decreased total and motor tic severity (17).However, CBIT is not widely available in Japan due to a considerable lack of well-trained therapists. Although there is a Japanese translation of the manual established by Woods et al. (6), which was published in 2018, training opportunities for learning CBIT procedures are limited among therapists. Moreover, CBIT is not covered by public health insurance in Japan; thus, the cost burden on patients is substantial. Therefore, the current study aimed to assess the preliminary efficacy, feasibility, and acceptability of remotely administered group CBIT (RG-CBIT) for reducing tics in children with TS via an open-case series.
Materials and methods
Study design and ethical considerations
This was an open-case series that utilized the AB design study (two-phase design comprising a baseline and an intervention phase). The recruitment phase was 4 weeks; the baseline phase, 10 weeks; and the intervention phase, 10 weeks. Clinical assessments were performed 5 days before baseline (Ax1 assessment 1) and the first session (Ax2 assessment 2), and 5 days after the end of the sessions (Ax3 assessment 3). Standard care, including medication treatment, was continued (not changed) throughout the study period.Written informed consents were obtained from the participants. This study was approved by the Ethical Committee of Dokkyo Medical University Saitama Medical Center (21019).
Participants
The inclusion criteria were as follows: (a) individuals aged between 6 and 15 years, (b) those with a diagnosis of TS based on the DSM-5 criteria (18), (c) those with a score of ≥ 14 for the total tic severity score on the Yale Global Tic Severity Scale (YGTSS), and (d) those who are medication free or on a stable medication for the treatment of tics, obsessive-compulsive disorder (OCD), and attention deficit hyperactivity disorder (ADHD) for at least 6 weeks, without planned changes during the study period. The exclusion criteria were as follows: (a) individuals with a diagnosis of other psychiatric disorders except for TS, ADHD, and OCD based on the DSM-5 criteria, (b) those with any serious physical disease, psychosocial, or neurological condition requiring treatment, (c) those with previous behavioral therapy for TS, and (d) those with lack of accessible home computer or tablet device and/or high-speed internet connection.Three Japanese children aged between 6 and 13 years and diagnosed with TS were recruited from Child Development and Psychosomatic Medicine Center, Dokkyo Medical University Saitama Medical Center, in February 2021. The clinical characteristics were obtained during the recruitment phase (as shown in Table 1).
Ax, assessment; YGTSS, Yale Global Tic Severity Scale; CGI-S, The Clinical Global Impression-severity score; CGI-I, The Clinical Global Impression-Improvement scale; PUTS, The Premonitory Urge of Tics Scale; SDQ, The Strength and Difficulties Questionnaire; CSQ-8J, The Japanese version of the Client Satisfaction Questionnaire-8; J-WAI-SR, The Japanese version of the Working Alliance Inventory-Short Revised; Modified-TEI, Modified version of the Treatment Evaluation Inventory.
Schedule of assessments.Ax, assessment; YGTSS, Yale Global Tic Severity Scale; CGI-S, The Clinical Global Impression-severity score; CGI-I, The Clinical Global Impression-Improvement scale; PUTS, The Premonitory Urge of Tics Scale; SDQ, The Strength and Difficulties Questionnaire; CSQ-8J, The Japanese version of the Client Satisfaction Questionnaire-8; J-WAI-SR, The Japanese version of the Working Alliance Inventory-Short Revised; Modified-TEI, Modified version of the Treatment Evaluation Inventory.
Yale global tic severity scale (19)
The YGTSS result was the primary outcome measure for evaluating the preliminary efficacy of the intervention for reducing tics. YGTSS is a semi-structured interview that is the gold standard for tic assessment. It yields two separate 0–50-point scales. The Total Tic Severity scale can be used to assess the severity of motor and vocal tic symptoms across the domains of tic number, frequency, intensity, complexity, and interference. The Tic Impairment scale assesses the extent to which the tics lead to impairment in the child’s daily life and activities (impairment scale score: 0–50). In both scales, higher scores indicate more severe tic symptoms or impairment.
Clinical global impression (20)
The Clinical Global Impression (CGI) rating scale is one of the most widely used assessment scales for assessing symptom severity and treatment response in intervention studies of patients with mental disorders. The CGI Severity score (CGI-S) is an observer-rated seven-point scale for evaluating illness severity at the time of assessment (scored between 1: normal, not at all ill and 7: among the most extremely ill patients). The seven-point CGI Improvement scale (CGI-I) rates improvement from 1 (very much improved) and 7 (very much worse due to intervention). A rating of 4 indicates that a patient did not experience any improvement after the intervention.
Premonitory urge of tics scale (21, 22)
Premonitory Urge of Tics Scale (PUTS) is a 9-item self-reported questionnaire scored from 1 to 4 (with a total score of 9–36), which is commonly used to assess premonitory urge strength. The Japanese version was designed using rigid methods, including translation and back translation, and with sufficient internal and concurrent validity.
Strength and difficulties questionnaire (23, 24)
Strength and Difficulties Questionnaire (SDQ) is a 25-item questionnaire that is used to assess the emotional and behavioral perspective of children. It was answered by the parents in this study. These items comprise five scales, which are as follows: emotional symptoms, conduct problems, hyperactivity/inattention, peer relationships problem, and prosocial behavior. The previous four subscales were added together to generate the total difficulty score (range: 0–40) (based on 20 items), with higher scores indicating more severe conditions.
Japanese version of the client satisfaction questionnaire-8 (25, 26)
Client Satisfaction Questionnaire-8 (CSQ-8) is an 8-item self-report questionnaire providing comprehensive measures of patient or client satisfaction with services in the medical and mental health primary care. Each item was scored from 1 to 4 (with a total score of 8–32), with higher scores representing higher satisfaction.
Japanese version of the working alliance inventory-short revised (27, 28)
Working Alliance Inventory-Short Revised (WAI-SR) is a recently refined self-reported questionnaire evaluating the therapeutic alliance that assesses three key aspects: agreement on the tasks of therapy, agreement on the goals of therapy, and development of an affective bond. It contains 12 questions according to the 7-point Likert scale (with a total score of 12–84), with higher scores indicating good alliance.
Modified version of the treatment evaluation inventory (29, 30)
Treatment Evaluation Inventory (TEI) is a commonly used measure of treatment acceptability. Modified TEI contains 11 items divided into two subscales: (a) general acceptability scale (8 items) and (b) negative aspect subscale (3 items). Each item is seven-point Likert scale (with a total score of 11–77). A score of 44 indicates moderately favorable attitudes toward the treatment, with higher scores representing favorable treatment.
Results
Three participants attended all the sessions and completed all assessments.Figure 2 shows the YGTSS scores. During baseline (between Ax1 and Ax 2), the Total Tic Severity scale score did not change. However, after the intervention, the scores decreased by 9, 9, and 3 points for cases 1, 2, and 3, respectively. The score reduced by an average of 7.0. The Tic Impairment scale score did not change at baseline. However, it decreased by 10, 0, and 10 points for cases 1, 2, and 3, respectively, after the intervention.
FIGURE 2
Baseline and post-treatment YGTSS. At baseline, the Total Tic Severity scale score did not change. However, after the intervention, those scores decreased by 9, 9, and 3 points for cases 1, 2, and 3, respectively. The score reduced by an average of 7.0.
Baseline and post-treatment YGTSS. At baseline, the Total Tic Severity scale score did not change. However, after the intervention, those scores decreased by 9, 9, and 3 points for cases 1, 2, and 3, respectively. The score reduced by an average of 7.0.Table 3 depicts the CGI and PUTS scores. The CGI-S and CGI-I score showed no change or worsened at baseline. Nevertheless, they showed improvement in two cases after the intervention (Table 3). Figure 3 shows the SDQ scores. After the intervention, the total SDQ scores increased by 6, 3, and 3 points for cases, respectively.
TABLE 3
Clinical outcomes (CGI and PUTS).
Ax 1
Ax 2
Ax 3
CGI-S
Case 1
5
5
3
Case 2
4
4
4
Case 3
3
5
4
CGI-I
Case 1
NA
4
2
Case 2
NA
4
4
Case 3
NA
5
3
PUTS
Case 1
20
13
29
Case 2
24
26
23
Case 3
21
21
19
Ax, Assessment; NA, not available; CGI-S, The Clinical Global Impression-severity score; CGI-I, The Clinical Global Impression-Improvement scale; PUTS, The Premonitory Urge of Tics Scale.
FIGURE 3
Baseline and post-treatment SDQ. After the intervention, the total SDQ scores increased by 6, 3, and 3 points for cases 1, 2, and 3, respectively.
Clinical outcomes (CGI and PUTS).Ax, Assessment; NA, not available; CGI-S, The Clinical Global Impression-severity score; CGI-I, The Clinical Global Impression-Improvement scale; PUTS, The Premonitory Urge of Tics Scale.Baseline and post-treatment SDQ. After the intervention, the total SDQ scores increased by 6, 3, and 3 points for cases 1, 2, and 3, respectively.Table 4 shows the process measures (CSQ-8J, J-WAI-SR, and Modified-TEI). The average CSQ-8J, J-WAI-SR, and Modified-TEI were 28.0, 75.0, and 65.3, respectively.
TABLE 4
Process measures (CSQ-8J, J-WAI-SR and TEI-R).
Measure
Scores range
Case 1
Case 2
Case 3
Average
CSQ-8J
8–32
29
30
25
28.0
J-WAI-SR
12–84
84
75
66
75.0
Modified-TEI
11–77
67
69
60
65.3
CSQ-8J, The Japanese version of the Client Satisfaction Questionnaire-8; J WAI-SR, The Japanese version of the Working Alliance Inventory-Short Revised; Modified-TEI, Modified version of the Treatment Evaluation Inventory.
Process measures (CSQ-8J, J-WAI-SR and TEI-R).CSQ-8J, The Japanese version of the Client Satisfaction Questionnaire-8; J WAI-SR, The Japanese version of the Working Alliance Inventory-Short Revised; Modified-TEI, Modified version of the Treatment Evaluation Inventory.
The original contributions presented in this study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.
Ethics statement
The studies involving human participants were reviewed and approved by the ethical committee of Dokkyo Medical University Saitama Medical Center (21019). Written informed consent to participate in this study was provided by the participants’ legal guardian/next of kin.
Author contributions
TI, KT, and JI collected patient’s data. KT and JI facilitated the sessions. TI, KT, and DW compiled the manuscript. TI, KT, and RS participated in the design of this study. DW and RS supervised this research. All authors reviewed the manuscript and approved it in its current form and have approved the ordering of authorship.
Authors: John Piacentini; Douglas W Woods; Lawrence Scahill; Sabine Wilhelm; Alan L Peterson; Susanna Chang; Golda S Ginsburg; Thilo Deckersbach; James Dziura; Sue Levi-Pearl; John T Walkup Journal: JAMA Date: 2010-05-19 Impact factor: 56.272
Authors: Emily J Ricketts; Amy R Goetz; Matthew R Capriotti; Christopher C Bauer; Natalie G Brei; Michael B Himle; Flint M Espil; Ívar Snorrason; Dagong Ran; Douglas W Woods Journal: J Telemed Telecare Date: 2015-07-13 Impact factor: 6.184
Authors: J F Leckman; M A Riddle; M T Hardin; S I Ort; K L Swartz; J Stevenson; D J Cohen Journal: J Am Acad Child Adolesc Psychiatry Date: 1989-07 Impact factor: 8.829
Authors: Chris Hollis; Charlotte L Hall; Rebecca Jones; Louise Marston; Marie Le Novere; Rachael Hunter; Beverley J Brown; Charlotte Sanderson; Per Andrén; Sophie D Bennett; Liam R Chamberlain; E Bethan Davies; Amber Evans; Natalia Kouzoupi; Caitlin McKenzie; Isobel Heyman; Kareem Khan; Joseph Kilgariff; Cristine Glazebrook; David Mataix-Cols; Tara Murphy; Eva Serlachius; Elizabeth Murray Journal: Lancet Psychiatry Date: 2021-09-01 Impact factor: 27.083